ASCENTIA DAFMIN TABLET
ASCENTIA DAFMIN TABLET : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL20106131TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- BIO-SCIENCE MARKETING SDN. BHD.
- Manufacturer
- HERBAL SCIENCE SDN. BHD.
- Registration date
- 2025-10-23
- Published validity end
- 2030-10-23
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Citrus aurantium | Citrus aurantium[500 mg,1200 mg] | Not identified |
| Aesculus hippocastanum | Aesculus hippocastanum[100 mg,1200 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Citrus aurantium[500 mg,1200 mg],Aesculus hippocastanum[100 mg,1200 mg]
- Valid until
- 2030-10-23
- Registration date
- 2025-10-23
- Published description
- NATURAL PRODUCT
- Licence holder
- BIO-SCIENCE MARKETING SDN. BHD.
- Producer
- HERBAL SCIENCE SDN. BHD.
- Published name
- ASCENTIA DAFMIN TABLET
- Published reference
- 202007073931T
- Registration number
- MAL20106131TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20106131TC
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.